| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
| mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-06 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0001 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |